{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:55:38Z","timestamp":1781837738964,"version":"3.54.5"},"reference-count":0,"publisher":"Avens Publishing Group","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharm Pharmacol"],"DOI":"10.13188\/2327-204x.1000032","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T08:42:54Z","timestamp":1607330574000},"source":"Crossref","is-referenced-by-count":5,"title":["Aticaprant (Clinically Developed Kappa-Opioid Receptor Antagonist) Combined With Naltrexone Prevents Alcohol \u201cRelapse\u201d Drinking"],"prefix":"10.13188","volume":"9","author":[{"given":"Y","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5316","published-online":{"date-parts":[[2022]]},"container-title":["Journal of Pharmaceutics & Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.avensonline.org\/fulltextarticles\/JPP-2327-204X-09-0032.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T09:28:22Z","timestamp":1657618102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.avensonline.org\/fulltextarticles\/JPP-2327-204X-09-0032.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.13188\/2327-204x.1000032","relation":{},"ISSN":["2327-204X"],"issn-type":[{"value":"2327-204X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}